AlzeCure is sponsored by           



AlzeCure aims to develop innovative therapies for the treatment of Alzheimer ́s disease and related neurodegenerative disorders, as well as unique medical technologies that will enable us to detect and monitor treatment effect in patients. We will develop our ongoing proprietary research projects through preclinical discovery into clinical phase. AlzeCure will also act as an industry-standard incubator for novel drug discovery projects sourced and acquired through our extensive network in academia and industry. AlzeCure is continuously looking for new joint collaborative projects in the neurodegeneration area.

AlzeCure focuses on two different scientific core areas:

Innovative therapies for Alzheimer’s disease
Medical technology focusing on biomarkers

Key features in AlzeCure’s research platform:

  • Translational screening cascade
  • Fully integrated translational thinking from project start to the clinic
  • Phenotypic screening
  • Highly context relevant phenotypic screens will increase pipeline success Proprietary medical technology allowing conclusive early concept testing in patients
  • Shorter timelines and reduced cost to Proof of Concept (PoC) in animals and in man
  • Collaborative business model - Collaboration with a financial up-side for both parties